中国生化药物杂志2017,Issue(4) :275-277.DOI:10.3969/j.issn.1005-1678.2017.04.091

前列地尔对120例2型糖尿病周围神经病患者的神经传导速度及血流状况的影响

The impact analysis of alprostadil on nerve conduction velocity and blood flow status of 120 patients with type 2 diabetic peripheral neuropathy

楼琴华 周伟斌
中国生化药物杂志2017,Issue(4) :275-277.DOI:10.3969/j.issn.1005-1678.2017.04.091

前列地尔对120例2型糖尿病周围神经病患者的神经传导速度及血流状况的影响

The impact analysis of alprostadil on nerve conduction velocity and blood flow status of 120 patients with type 2 diabetic peripheral neuropathy

楼琴华 1周伟斌2
扫码查看

作者信息

  • 1. 杭州市富阳区第一人民医院 内分泌科,浙江 杭州 311401
  • 2. 浙江大学附属第一医院内分泌科,浙江 杭州 310003
  • 折叠

摘要

目的 探究前列地尔对2 型糖尿病周围神经病患者的神经传导速度及血流状况的影响.方法 将我院收治的120 例2 型糖尿病周围神经病变患者纳入研究,按入院先后均分为观察组和对照组.对照组患者采用甲钴胺进行静脉滴注治疗;观察组在上述治疗的基础上采用前列地尔进行静脉滴注治疗,治疗时间均为2 w.制定相关的临床疗效标准对2 组患者的临床治疗效果进行对比性评价,并就2 组患者在治疗前后的神经传导速度和血流状况进行比较.结果 观察组的总有效率为86.67%,对照组为71.67%,组间比较差异有统计学意义( P <0.05).治疗前,2组的各项神经传导速度和血流变学指标水平均差异无统计学意义.治疗后,观察组的正中神经MNSV、腓总神经MNSV以及正中神经SNCV、腓总神经SNCV分别为(54.14±7.29)m/s、(50.22±7.85)m/s、(48.47±7.64)m/s、(47.04±6.58)m/s,均明显高于对照组(50.11±6.85)m/s、46.24±7.08)m/s、(44.58±7.21)m/s、(43.57±6.55)m/s;而观察组的血浆黏度、高切黏度和低切黏度水平分别为(2.48±0.29)MPa/s、(4.87±0.41)MPa/s、(33.46±2.77)MPa/s,均明显低于对照组(2.83±0.33)MPa/s、(5.23±0.44)MPa/s、(34.83±2.54)MPa/s,组间差异有统计学意义( P <0.05).结论 前列地尔能够显著改善2型糖尿病周围神经病变患者的神经传导速度及其血流状况,具有较好的临床治疗效果.

Abstract

Objective To research the effects of alprostadil on nerve conduction velocity and blood flow status of 120 patients with type 2 diabetic peripheral neuropathy.Methods 120 cases of patients with type 2 diabetic peripheral neuropathy in our hospital were selected as the research objects.According to the hospital admission,they were divided into observation group and control group.The control group was treated with Mecobalamin intravenous drip treatment; on the basis of the above treatment,the observation group was treated with alprostadil intravenous drip treatment,and the treatment time was two weeks.To established the relevant clinical curative effect standard for evaluated and compared the clinical therapeutic effect of the two groups.Before and after treatment,compared the nerve conduction velocity and blood flow between the two groups.Results The total effective rate of the observation group was 86.67%,and the control group was 71.67%,the difference was statistically significant(P<0.05).Before treatment,there were no significant differences between the two groups in nerve conduction velocity and blood rheology indexes.After treatment,the median nerve MNSV,common nerve MNSV,median nerve SNCV,common nerve SNCV of the observation group were(54.14±7.29)m/s,(50.22±7.85)m/s,(48.47±7.64m/s and(47.04±6.58m/s respectively,were significantly higher than the control group(50.11±6.85)m/s,(46.24±7.08)m/s,(44.58±7.21)m/s,(43.57±6.55)m/s.The observation group of plasma viscosity,high shear viscosity and low shear viscosity levels were(2.48±0.29)Mpa/s,(4.87±0.41)Mpa/s,(33.46±2.77)Mpa/s,were significantly lower than the control group(2.83±0.33)Mpa/s,(5.23±0.44)Mpa/s,(34.83±2.54)Mpa/s,and the differences between the groups were statistically significant(P<0.05).Conclusion Alprostadil can significantly improve nerve conduction velocity and blood flow condition in patients with type 2 diabetic peripheral neuropathy,has better clinical curative effect.

关键词

前列地尔/糖尿病周围神经病变/神经传导速度/血流状况

Key words

alprostadil/diabetic peripheral neuropathy/nerve conduction velocity/blood flow

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量1
参考文献量13
段落导航相关论文